Nexmyra Biologics Private Limited
About Nexmyra Biologics Private Limited
Data last updated:
Nexmyra Biologics Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 13 November 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U74999KA2018PTC118457. Its GSTIN is 33AAICB1160B1ZF (Tamil Nadu).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It was formerly known as Baruch Pharmaceuticals Private Limited. It is led by directors Abdulmajee Sheriff and Kajamohideen Reshma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No 9 7th B Main Muthayal Nagar, Bangalore, Karnataka, India – 560054.
As per the financials filed for FY 2022, the company reported a revenue of ₹1.35 Cr, a growth of 57% compared to the previous year. For the same year it recorded a net profit of ₹2.29 Lakh (net margin 1.7%) and EBITDA of ₹96,870 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 184% over three years.
Company details
Contact details
Nexmyra Biologics Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo 9 7th B Main Muthayal Nagar, Bangalore, Karnataka, India – 560054
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Nexmyra Biologics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nexmyra Biologics Private Limited
FY 2025 filings availableNexmyra Biologics Private Limited reported revenue of ₹1.35 Cr (up 57% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 184% over three years, including 57% growth in the latest year. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹1.35 Cr | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹96,870 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹2.29 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.7% | |||
| Net Profit Margin | 1.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Nexmyra Biologics Private Limited, buy the company report.
Board of directors of Nexmyra Biologics Private Limited
Nexmyra Biologics has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdulmajee Sheriff | Director | 13 Apr 2022 | 4 Years 6 Months | Current |
| Kajamohideen Reshma | Director | 27 Nov 2025 | 0 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Nexmyra Biologics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nexmyra Biologics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nexmyra Biologics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICB1160B1ZF | Tamil Nadu | Active | 11 Dec 2018 |
To see the full GST registrations and return filing status of Nexmyra Biologics Private Limited, buy the company report.
Recent activity
Nexmyra Biologics Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Kajamohideen Reshma was appointed as Director on 27 Nov 2025.
Frequently asked questions
Nexmyra Biologics is an active private limited company based in Bangalore, Karnataka, India. The company works in other services, within the business services industry. It was incorporated on 13 November 2018 (8+ years old) and is registered under CIN U74999KA2018PTC118457.
Nexmyra Biologics has 2 current directors:
- Abdulmajee Sheriff - Director
- Kajamohideen Reshma - Director
The latest financial statements of Nexmyra Biologics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Nexmyra Biologics is 33AAICB1160B1ZF, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Nexmyra Biologics is U74999KA2018PTC118457. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nexmyra Biologics was incorporated on 13 November 2018, making it 8+ years old. It is registered with the Registrar of Companies, Bangalore.
Kajamohideen Reshma was appointed as Director on 27 Nov 2025. Mohammed Aniesh ceased to be Director on 18 Apr 2022. Mohammed Hussain Rejiyasettu was appointed as Director on 18 Apr 2022. Nexmyra Biologics has 5 board changes on record in total.
The registered office of Nexmyra Biologics is at No 9 7th B Main Muthayal Nagar, Bangalore, Karnataka, India – 560054.
Nexmyra Biologics operates in the business services industry, in the other services segment.
Yes. Nexmyra Biologics was formerly known as Baruch Pharmaceuticals Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
